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Abstract: The main aim of this study was to evaluate the use of essential oils (EOs) as an alternative
to synthetic fungicides used in the control of cobweb disease of button mushroom (Agaricus bisporus)
caused by Cladobotryum mycophilum. The EOs used were obtained by hydrodistillation from five
Mediterranean aromatic species (Lavandula × intermedia, Salvia lavandulifolia, Satureja montana,
Thymus mastichina, and Thymus vulgaris), analyzed by gas chromatography, and tested in vitro
for their antifungal activity against C. mycophilum. In vitro bioassays showed that the EOs obtained
from T. vulgaris and S. montana (ED50 = 35.5 and 42.8 mg L−1, respectively) were the most effective
EOs for inhibiting the mycelial growth of C. mycophilum, and were also the most selective EOs
between C. mycophilum and A. bisporus. The in vivo efficacy of T. vulgaris and S. montana EOs at
two different concentrations (0.5 and 1%) were evaluated in two mushroom growing trials with
C. mycophilum inoculation. The treatments involving T. vulgaris and S. montana EOs at the higher dose
(1% concentration) were as effective as fungicide treatment. The effect of these EOs on mushroom
productivity was tested in a mushroom cropping trial without inoculation. They had a strong
fungitoxic effect at the first flush. However, a compensatory effect was observed by the end of the
crop cycle and no differences were observed in biological efficiency between treatments. The main
compounds found were carvacrol and p-cymene for S. montana, and p-cymene and thymol for
T. vulgaris. These results suggest that T. vulgaris and S. montana EOs may be useful products to manage
cobweb disease if used as part of an integrated pest management (IPM) program.
Keywords: Agaricus bisporus; antifungal activity; biofungicides; mushroom cultivation;
Satureja montana; Thymus vulgaris
1. Introduction
Cobweb disease, caused by the mycopathogenic fungus Cladobotryum mycophilum (Oudem.) W.
Gams & Hooz., is found in all mushroom-growing countries worldwide. The disease is prevalent
especially in white button mushroom (Agaricus bisporus (Lange) Imbach) [1–5], king oyster mushroom
(Pleurotus eryngii (DC.:Fr.) Quél.) [6–8], and oyster mushroom (Pleurotus ostreatus (Jacq.) P. Kumm.) [9].
Cobweb disease is associated with final flushes and conditioned by the season. The pathogen develops
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into a cottony growth of mycelium, colored grey to white, which spreads over the casing layer and
mushrooms. Cobweb mycelium becomes dense and sometimes develops a rosy red or yellow hue.
The pathogen may grow over primordia and mushrooms, affecting the salability of the product [10].
Methods to control cobweb include strict hygiene measures to prevent dispersion of the conidia
and the application of fungicides, mainly prochloraz and metrafenone [11–13]. However, the use of
conventional chemical fungicides is gradually being limited due to its negative effects on human health,
environmental safety, pathogen resistance, etc. Therefore, improvements in the hygiene conditions of
farming facilities, as well as a better understanding of the new, environment-friendly, and effective
control methods are necessary to minimize the use of chemicals in the mushroom industry.
In order to develop alternatives to chemical agents within an integrated management strategy for
cobweb disease, the possible use of essential oils (EOs) would present many advantages in terms of
sustainability, low persistence in the environment, biological activity, mode of action, effectiveness,
and toxicity. For many years, EOs have been studied as sources of natural antifungal products and
they have been screened for their potential uses as alternative remedies for the treatment of many
phytopathogenic fungi [14–16]. More specifically, some EOs have also been tested as control agents
against the most important diseases of white button mushroom. The EOs from Cinnamomun zeylanicum
Blume, Origanum vulgare L., Syzygium aromaticum (L.) Merr. & L.M. Perry, Thymus vulgaris L., Zataria
multiflora Boiss, and Satureja hortensis L. showed strong in vitro activity against Lecanicillium fungicola
var. fungicola (Preuss) Zare & W. Gams [17–19]; Lippia citriodora (Cav.) Kunth, Cymbopogon citratus (D.C)
Stapf, and T. vulgaris EOs were found to substantially inhibit the growth of Mycogone perniciosa (Magnus)
Delacroix [20]; and S. aromaticum EO also exhibited strong in vitro inhibition against C. mycophilum [21].
Melaleuca alternifolia (Maiden & Betchee) Cheel essential oil was less toxic in vitro than prochloraz-Mn
against Cladobotryum dendroides (Bull.:Fr.) W. Gams & Hooz., although in in vivo trials it caused
a significant reduction in cobweb disease levels compared with a control without fungicide [22].
Therefore, these studies suggest that EOs can be considered as suitable biocontrol agents for the control
of mushroom diseases, particularly the cobweb disease.
Moreover, it must be borne in mind that the cultivation of aromatic plants is an important
agricultural activity in many parts of Spain, especially in certain zones of Castilla–La Mancha,
near the most important mushroom cultivation centres. Several preliminary studies focused on
native Mediterranean aromatic species (Lavandula spp., Thymus spp., Salvia lavandulifolia Vahl,
Rosmarinus officinalis L., Santolina chamaecyparissus L., Hyssopus officinalis L., and Satureja montana
L.), adapted to local environmental conditions, have been carried out. In this respect, antifeedant,
insecticidal, phytotoxic, nematicidal, antibacterial, and antifungal activities of EOs from the
above-mentioned species have been reported [23,24]. However, many factors including the origin of
the cultivar or variety, environment (climatic, seasonal, and geographical), type of plant material used,
plant nutrition, application of fertilizers, and the method of extraction have influence not only in the
identity of main compounds of an essential oil but also in their percentage, and thereby might affect its
biocidal properties [25,26].
The aim of this study was to: (i) characterize the chemical composition of five EOs from
Mediterranean aromatic plants belonging to the Lamiaceae family, such as Lavandula × intermedia Emeric
ex Loiseleur, Salvia lavandulifolia Vahl, Satureja montana L., Thymus mastichina L., and Thymus vulgaris L.;
(ii) determine the effectiveness of the above-mentioned EOs in cobweb control by in vitro antifungal
activity bioassays and in vivo mushroom trials involving inoculation with C. mycophilum; and (iii) test
the toxicity of these EOs to A. bisporus mycelium and/or mushroom yield.
2. Materials and Methods
2.1. Plant Material
The species used for EO extraction (L. × intermedia (lavandin), S. lavandulifolia (Spanish sage),
S. montana (savory), T. mastichina (white thyme), and T. vulgaris (thyme)) were cultivated in the
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experimental fields of CIAF Albaladejito-IRIAF (Cuenca, Spain). Harvests of aerial parts from plants
(inflorescences, leaves, and stems) were made at the flowering phenological stage.
2.2. Essential Oil Extraction
The plant material was dried in an environmental chamber at 28 ◦C until a constant weight is
obtained before extraction. Samples were hydrodistilled using a Clevenger-type apparatus for 4 hours
according to the method recommended in the European Pharmacopoeia [27].
2.3. Components Identification and Quantification
The chemical components of the EO were identified by gas chromatography. GC-FID analyses
were carried out using a Varian 400-GC gas chromatograph operated with a split/splitless injector
(Varian Inc., Palo Alto, CA, USA). Column (non-polar): VF-5ms (cross-linked phenyl-methyl siloxane),
60 m × 0.25 mm × 0.25 µm film thickness (Varian Inc., Palo Alto, CA, USA). Temperature program:
from 70–95 ◦C at 3 ◦C/min and from 95–240 ◦C (5 min) at 4 ◦C/min. Injection temperature: 250 ◦C.
Injection volume: 0.5 µL. Carrier gas: He (1 mL/min). Injection mode: split (100:1). FID (300 ◦C):
H2 flow, 35 mL/min; air flow, 300 mL/min; and make up flow, 29 mL/min. Sampling rate: 50 ms.
Relative retention times and Kovats Index of corresponding reference standards (Acros Organics
BVBA/SPRL, Fisher Scientific S.A., and Sigma Aldrich Química A.) were used to identify the major
components using the Adams library [28]. The relative amounts of individual components were
calculated according to the area of the chromatographic peaks using Galaxie® Chromatography
software (Varian Inc., Walnut Creek, CA, USA).
2.4. Fungal Isolates
Six Cladobotrym mycophilum isolates obtained from mushroom farms located in Castilla–La Mancha
and La Rioja (Spain) were used in vitro to test for antifungal activity and selectivity index of five EOs.
Isolates were collected between 2015 and 2017 from Agaricus bisporus crops with symptoms of cobweb
disease, maintained on potato dextrose agar (PDA; Oxoid, Basingstoke, England) medium at 22 ◦C in
darkness, and characterized morphologically and molecularly [10,29,30]. Two commercial mushroom
strains (Mispaj 400 (Mispaj S.L., Pradejón, La Rioja, Spain) and Gurelan 90 (Gurelan S. Coop., Huarte,
Pamplona, Spain)) were used to determine the toxic effect of the EOs on A. bisporus mycelium.
2.5. In Vitro Antifungal Activity and Selectivity Index of the Essential Oils on Mycelium Growth of
Cladobotryum Mycophilum and Agaricus bisporus
The antifungal activities of the EOs against C. mycophilum and A. bisporus were calculated by
in vitro sensitivity assays, with slight modifications [8,13]. The five EOs (containing 0.01% Tween
20) from each plant sample were added to molten sterile malt extract agar (MEA) medium at 45 ◦C
prior to solidification. The EO concentrations selected for the C. mycophilum isolates were: Lavandula
× intermedia (46, 92, 183, 366, and 732 mg L−1), Thymus mastichina (325, 650, 1300, 2600, and 5200 mg
L−1), Thymus vulgaris (5, 9, 18, 36, and 72 mg L−1), Salvia lavandulifolia (83, 165, 330, 660, and 1320 mg
L−1), and Satureja montana (10, 21, 41, 82, and 164 mg L−1). All EO-amended media were prepared
a maximum of 24 h before use. Control consisted of unamended plates. Four replicates were used per
combination of isolate and EO concentration. The experiment was repeated twice.
The percentage of relative inhibition (PI) of mycelial growth was calculated using the formula: (PI =
100(C−T)/C, where C = rate of growth of the control and T = rate of growth in treated dishes). ED50 values
(mg L−1 of essential oil inhibiting radial mycelial growth by 50%) were calculated using the data analysis
software PoloPlus, Probit, and Logit Analysis (LeOra Software Company, Petaluma, CA, USA) [31].
The in vitro antifungal activity of these EOs on A. bisporus was evaluated using essential
oil-amended agar-compost medium [32], following the methodology described for the pathogen.
The studied EOs (containing 0.01% Tween 20) were added to produce final concentrations of 10, 100,
1000, and 10,000 mgL−1. The unamended medium was used as a control. A mushroom spawn grain
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covered with actively growing mycelium of two commercial mushroom strains were placed on the
medium and incubated for 10 days at 25 ◦C in the dark.
A selectivity index (SI) for each essential oil was calculated as the ratio between the mean ED50
values for the C. mycophilum isolates tested and the corresponding mean ED50 values were estimated for
the two commercial A. bisporus strains. Selectivity indices lower than 0.1 express acceptable selective
toxicity between the pathogen and the host [33].
ED50 values were examined using analysis of variance (ANOVA). ED50 values, where
necessary, were transformed by log(x + 1) before analysis and were back-transformed for the tables.
Mean comparisons were performed using the Fisher’s LSD (least significant difference) test to examine
if differences were significant at p < 0.05. Statistical analyses were made using Statgraphics Centurion
XV (Statistical Graphics Corp., Princeton, NJ, USA).
2.6. Effectiveness of EOs Treatments in Mushroom Growing Trials with Cladobotryum Mycophilum Inoculation
The effectiveness of EOs to control cobweb disease was tested in two cropping trials (A and B)
carried out in experimental mushroom growing rooms (20 m3), according to the standard practices
used in mushroom farms in Spain. In each trial, experimental trays (0.15 m2) filled with 10 kg
commercial phase III compost (Champinter SCL, Villamalea, Albacete, Spain) and spawned at 1% with
the commercial mycelium Sylvan®A15 (Sylvan Inc., Kittanning, PA, USA) were used. The trays were
arranged in shelves at three different levels in a completely randomized block design. Each trial was
conducted using 42 trays, 36 of which were inoculated with C. mycophilum, while the remaining 6 trays
were sprayed with water and used as uninoculated control. The 36 inoculated trays were divided into
five treatments and an inoculated control, with six replicates per treatment.
On casing day (day 0) of the cropping cycle, the compost was cased with a peat-based casing as
a 30–35 mm thick layer (5.5 L per experimental tray). The environmental conditions were: compost
temperature of about 24–26 ◦C, 93–98% relative humidity (RH) with 8000→3200 ppm carbon dioxide
(CO2). Inoculation was done eleven days after casing by watering 20 mL per tray of a conidial
suspension of C. mycophilum (106 conidia m−2) onto the surface of the casing layer in the inoculated
treatments. The non-inoculated control was sprayed with sterile distilled water. The C. mycophilum
isolate CS1, collected in September 2016 in a mushroom farm from Casasimarro (Castilla–La Mancha,
Spain), was used as an inoculum and prepared on the day of inoculation. The concentration of the
conidial suspension was determined using a hemocytometer and diluted in sterile distilled water to
7.5 × 103 conidia mL−1.
Based on the in vitro antifungal activity results given in Table 3, the Satureja montana and
Thymus vulgaris EOs were selected. Essentials oil formulations were diluted in tap water to reach 0.5%
(trial A) and 1% (trial B) concentration (containing 0.01% Tween 20) and added as a single drench
application, at a rate of 150 mL per tray. For each of the EOs selected, there were two treatments
and six replicate trays per treatment. The first treatment (BI: before inoculation) was applied 1 day
before inoculating with conidia of C. mycophilum, while the second treatment (AI: after inoculation)
was applied 2 days after inoculation. There were three controls: first, a non-inoculated control (C),
in which drench applications were 150 mL tap water per tray; second, an inoculated control (IC),
each tray receiving a 20 mL conidial suspension of C. mycophilum, in which irrigation was by water
alone; and third (IMFC), also inoculated, but including the fungicide Vivando® (metrafenone 50% SC,
BASF Crop Protection Spain, Barcelona, Spain) at 1 mL L-1 per m2 on day 4, at a rate of 150 mL per tray
(Table 1).
Agronomy 2019, 9, 656 5 of 13
Table 1. Treatments applied in the mushroom crop trials.
Trials Code Inoculation(106 conidia m−2) a Treatment
b
A, B, and C C No Only tap water.
A and B IMFC Yes Vivando® at 1 ml L−1 on day 4.
A and B IC Yes Only tap water.
A IEO1B Yes Satureja montana essential oil at 0.5% applied 1 day beforeinoculation with Cladobotryum mycophilum, on day 10.
A IEO1A Yes Satureja montana essential oil at 0.5% applied 2 days afterinoculation with Cladobotryum mycophilum, on day 13.
A IEO3B Yes Thymus vulgaris essential oil at 0.5% applied 1 day beforeinoculation with Cladobotryum mycophilum, on day 10.
A IEO3A Yes Thymus vulgaris essential oil at 0.5% applied 2 days afterinoculation with Cladobotryum mycophilum, on day 13.
B IEO1B Yes Satureja montana essential oil at 1% applied 1 day beforeinoculation with Cladobotryum mycophilum, on day 10.
B IEO1A Yes Satureja montana essential oil at 1% applied 2 days afterinoculation with Cladobotryum mycophilum, on day 13.
B IEO3B Yes Thymus vulgaris essential oil at 1% applied 1 day beforeinoculation with Cladobotryum mycophilum, on day 10.
B IEO3A Yes Thymus vulgaris essential oil at 1% applied 2 days afterinoculation with Cladobotryum mycophilum, on day 13.
C MFC No Vivando® at 1 mL L−1 on day 4.
C EO1B No Satureja montana essential oil at 1% applied on day 10.
C EO1A No Satureja montana essential oil at 1% applied on day 13.
C EO3B No Thymus vulgaris essential oil at 1% applied on day 10.
C EO3A No Thymus vulgaris essential oil at 1% applied on day 13.
a Inoculation on day 11 after casing. b Dose per application: 1 L m−2 for each drench, 150 mL per tray.
In each trial, three flushes of mushrooms were harvested. Disease incidence (DI) was calculated
as a percentage value, based on the ratio of the crop area colonized by cobweb in each treatment to
the total colonized and non-colonized crop area. The affected area by cobweb was left uncovered for
24 hours. After that, this area was covered with a piece of damp paper and salt to avoid pathogen
dispersion [11,12]. The DI in the different trays was related to the uninoculated control disease
incidence average using the Abbot’s formula correction:
DIcorr = (DIexp − DIcont)/(1 − DIcont),
where DIexp = experimental treatment disease incidence, and DIcont = mean uninoculated control
disease incidence [34]. The effectiveness of EOs treatments was calculated based on the DI using
Abbott’s formula [35]:
Effectiveness (%) = [(DIin-cont − DIcorr)/DIin-cont] × 100,
where DIin-cont = disease incidence of the inoculated control and DIcorr = corrected disease incidence
of the treatment.
The disease incidence and the effectiveness of treatments were examined using ANOVA.
Mean comparisons were performed using the Fisher’s LSD test to examine if differences were
significant at p < 0.05. Statistical analyses were made using Statgraphics Centurion XV (Statistical
Graphics Corp., Princeton, NJ, USA).
2.7. Effect of EOs Treatments on Agaricus bisporus Yield
The effect of essential oils on A. bisporus yield was determined in a third cropping trial (trial C).
This trial was set up under conditions identical trial B. No conidial suspensions were applied in the
treatments (Table 1). The experiment was a randomized complete block design with five replicates.
The effect of essential oils and metrafenone treatments on A. bisporus yield was assessed by reference
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to daily recorded mushroom production (kg m−2 per flush and total yield). The effect of treatments
on mushroom productivity was evaluated by the biological efficiency of the crop and calculated as
the percentage ratio of the fresh weight of total yield of harvested mushrooms over the weight of dry
substrate at spawning and expressing the fraction as kg/100 kg compost. In addition, the earliness
(days to first harvest for each treatment) was expressed as the number of days between casing and
harvesting of the first flush.
An ANOVA was used to test for the effect of treatment and the different yield parameters.
Mean comparisons were performed using the Fisher’s LSD test to examine if differences were
significant at p < 0.05. Data were analyzed separately for each flush. Statistical analyses were made
using Statgraphics Centurion XV (Statistical Graphics Corp., Princeton, NJ, USA).
3. Results
3.1. Chemical Composition of the Essential Oils
The chemical composition of the main compounds of the five EOs is shown in Table 2.
Linalyl acetate (34.20%) was the most abundant component, followed by linalool (28.75%),
camphor (8.49%), and 1,8-cineole (6.90%), in L. × intermedia EO. The most abundant compound
in S. lavandulifolia EO was 1,8-cineole (20.90%), followed by β-pinene + β-myrcene (13.99%),
camphor (12.60%), and α-pinene (11.39%). The main components of S. montana EO were carvacrol
(17.22%), p-cymene (11.54%), and camphor (10.14%). In T. mastichina EO, 1,8-cineole (44.57%) and
linalool (29.89%) were the major components, while the main components of T. vulgaris EO were
p-cymene (29.67%) and thymol (25.78%).
Table 2. Percentages of the main compounds of the essential oils from Lavandula × intermedia,
Salvia lavandulifolia, Satureja montana, Thymus mastichina, and Thymus vulgaris.
Main Compounds a KIb RTc
Lavandula ×
intermedia
Salvia
lavandulifolia
Satureja
montana
Thymus
mastichina
Thymus
vulgaris
α-Pinene 943 11.40 td 11.39 7.86 2.33 1.73
Camphene 962 12.03 t 6.38 3.63 t t
β-Pinene +
β-Myrcene 991 12.97 1.22 13.99 8.40 4.42 2.68
p-Cymene 1033 14.52 t t 11.54 t 29.67
Limonene 1038 14.66 2.18 8.72 3.53 2.46 t
1,8-Cineole 1044 14.95 6.90 20.90 4.91 44.57 1.97
γ-Terpinene 1066 15.68 -e 1.4 6.79 t 7.55
Linalool 1102 17.12 28.75 t 2.1 29.86 4.59
Camphor 1165 19.32 8.49 12.60 10.14 - 1.54
α-Terpineol 1206 20.84 t t t 3.60 t
Linalyl acetate 1254 22.45 34.20 - - t t
Thymol 1290 24.09 - - 1.87 - 25.78
Carvacrol 1298 24.43 - - 17.22 - 2.41
trans-caryophyllene 1441 28.71 1.86 4.45 3.36 t 2.76
a Compounds listed in order of elution from an HP-5 column. b Kovats index. c Retention time (minutes). d Traces.
e Not detected.
3.2. In Vitro Antifungal Activity and Selectivity Index of the Essential Oils on Mycelium Growth of
Cladobotryum mycophilum and Agaricus bisporus
The most effective essential oils for inhibiting the in vitro mycelial growth of C. mycophilum were
T. vulgaris (ED50 = 35.5 mg L−1) and S. montana (ED50 = 42.8 mg L−1). In contrast, L. × intermedia (ED50
= 784.2 mg L−1), T. mastichina (ED50 = 627.3 mg L−1), and S. lavandulifolia (ED50 = 598.4 mg L−1) EOs
showed the lowest antifungal activity against C. mycophilum (Table 3). The activity of S. montana and
T. vulgaris EOs differed significantly from the rest of the EOs (F4,59 = 54.87; p = 0.0).
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Table 3. Mean effective dose (ED50 values ± SD (standard deviation)) of essential oils for isolates of
Cladobotryum mycophilum and Agaricus bisporus. Selectivity index (SI) between pathogen and host.
Essential Oil
Cladobotryum
mycophilum (n = 12)
Agaricus bisporus
(n = 4) Selectivity Index a
ED50 (mg L−1) ED50 (mg L−1)
Satureja montana 42.8 ± 33.4 ab 537.4 ± 192.1 b 0.08
Thymus vulgaris 35.5 ± 23.0 a 389.7 ± 131.5 b 0.09
Salvia lavandulifolia 598.4 ± 430.9 b 587.1 ± 177.4 b 1.02
Thymus mastichina 627.3 ± 183.9 b 175.7 ± 60.2 a 3.57
Lavandula × intermedia 784.2 ± 460.5 b 146.6 ± 39.2 a 5.35
a Selectivity index expressed as the ratio between the mean ED50 value of C. mycophilum for each essential oil and
the corresponding mean ED50 value of A. bisporus. b Values followed by different lowercase letters in the columns
indicate statistically significant differences at p = 0.05 according to Fisher’s LSD (least significant difference) test.
The in vitro antifungal activity of the EOs toward A. bisporus was highest in L. × intermedia (ED50
= 146.6 mg L−1) and T. mastichina (ED50 = 175.7 mg L−1) and the least toxic EOs in this respect were
S. lavandulifolia (ED50 = 587.1 mg L−1) and S. montana (ED50 = 537.4 mg L−1) (Table 3). Lavandula
x intermedia and T. mastichina EOs had significant differences from the rest of the EOs (F4,19 = 8.98;
p = 0.0007). According to values obtained for selectivity index, S. montana and T. vulgaris EOs showed
the best selective toxicity (SI = 0.08 and 0.09, respectively) between pathogen and host.
3.3. Effectiveness of EOs Treatments in Mushroom Growing Trials with Cladobotryum mycophilum Inoculation
In trial A, the first symptoms of cobweb were detected at the end of the first flush (day 28
after casing) in the IEO1B treatment, and in the second flush in IEO3B (day 31) and IEO1A (day 33)
treatments. Cobweb symptoms in C and IC appeared 39 days after casing. By the end of the crop
cycle, the disease incidence (DIcont) in the non-inoculated control (C) was 28.3%. This DIcont may
be due to cross-contamination incidents. In the inoculated control (IC), the DIcorr was 42.6%. In the
treatments IEO1B and IEO1A, the DIcorr was 73.2 and 47.3%, respectively, while in IEO3B and IEO3A
it was 26.7 and 24.4%. By contrast, when metrafenone (IMTF) was used, the DIcorr was 0% at the
end of the crop cycle. There were significant differences between IMTF and the rest of the treatments
(F6,41 = 5.54; p = 0.0004) (Figure 1). At the end of the crop cycle, the most effective treatments were
metrafenone (IMTF) and T. vulgaris (IEO3A and IEO3B) showing significant differences with S. montana
EO treatment (IEO1B) (F4,29 = 6.52; p = 0.0010) (Figure 2).
In trial B, the first symptom of disease was observed in treatment IC, 31 days after casing, at the end
of the second flush, followed by treatments IEO1B (34 days) and IEO1A (35 days). Cobweb symptoms
in C appeared 46 days after casing. At the end of the crop cycle, the DIcont in the non-inoculated
control (C) was 6.7%. In the inoculated control (IC), the DIcorr was 31.8% (Figure 1). In treatments
IEO1B and IEO1A, the DIcorr was 19.0 and 7.4%, respectively, while in IEO3B and IEO3A it was 4.7 and
3.0%. In the IMTF treatment it was 1.5%. There were significant differences between IC and C, IMTF,
IEO1A, IEO3B, and IEO3A treatments (F6,41 = 3.2; p = 0.0131) at the end of the crop cycle. The most
effective treatments at the end of the crop cycle were those involving metrafenone (IMTF), S. montana
EO (IEO1A) and T. vulgaris EO (IEO3B and IEO3A) (F4,29 = 2.37; p = 0.08) (Figure 2).
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Figure 1. Incidence of cobweb disease (DIcorr) of different essential oils and fungicide treatments in two
mushroom crop trials (A and B) with Cladobotryum mycophilum inoculation. Treatments are explained in
Table 1. For each trial, different letters on columns indicate significant difference according to Fisher’s
LSD (least significant difference) test at p = 0.05.
Figure 2. Effectiveness (EF) of different essential oils and fungicide treatments at the end of the crop
cycle in two mushroom crop trials (A and B) with Cladobotryum mycophilum inoculation. Treatments are
explained in Table 1. For each trial, different letters on columns indicate significant difference according
to Fisher’s LSD (least significant difference) test at p = 0.05.
3.4. Effect of EOs Treatments on Agaricus bisporus Yield
In trial C, metrafenone treatment (MTF) provided the highest yield at the first flush (Table 4),
followed by the control (C), while treatments with essential oils applied after inoculation (EO1A and
EO3A) had the lowest yield. The EO1A and EO3A treatments showed significant differences in yield
from the rest of the treatments (F5,29 = 5.55; p = 0.0016). At the second flush, the opposite was the case,
since the treatments with essential oils applied after inoculation (EO1A and EO3A) had the highest
yield, while treatments C and MTF had the lowest yields, with significant differences between EO3A
and C, MTF, EO1B, and EO3B (F5,29 = 3.55; p = 0.0152). At the end of the crop cycle, there were no
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significant differences between treatments in total yield or biological efficiency (F5,29 = 0.73; p = 0.6089).
Regarding earliness, EO1B, EO3B, and EO3A showed a significant delay of 1 day compared with C
and MTF (F5,29 = 16.32; p = 0.0000).
Table 4. Effect of the essential oils and fungicide treatments on Agaricus bisporus quantitative
production parameters.
Treatments a
Mushroom Yield (kg m−2) Biological Efficiency
(kg dt−1 Compost)
Earliness (Days
from Casing)1st Flush 2nd Flush Total
C 11.0 ± 3.8 bb 5.8 ± 0.9 ab 16.8 ± 3.4 a 67.1 ± 13.8 a 24.0 ± 0.2 a
MTF 12.1 ± 2.6 b 5.0 ± 0.6 a 17.1 ± 2.8 a 68.4 ± 11.1 a 23.9 ± 0.3 a
EO1B 9.4 ± 1.1 b 6.6 ± 4.0 ab 16.0 ± 3.9 a 64.1 ± 15.4 a 25.4 ± 0.3 c
EO1A 6.1 ± 2.2 a 9.1 ± 2.6 bc 15.1 ± 1.4 a 60.4 ± 5.4 a 24.6 ± 0.5 b
EO3B 10.7 ± 1.3 b 7.2 ± 2.0 ab 18.0 ± 1.8 a 71.7 ± 7.2 a 25.2 ± 0.3 c
EO3A 6.2 ± 2.6 a 11.3 ± 4.1 c 17.5 ± 2.0 a 70.0 ± 8.0 a 25.0 ± 0.5 bc
SED 1.08 1.22 1.2 4.81 0.16
LSD 4.72 5.32 5.26 21.05 0.69
d.f. 29 29 29 29 29
a Treatments are explained in Table 1. b Values followed by different lowercase letters in the columns indicate
statistically significant differences at p = 0.05 according to Fisher’s LSD (least significant difference) test. SED:
Standard error of the difference between two means. LSD: Least significant difference between two means. d.f.:
Degrees of freedom associated with the LSD and SED.
The treatment of EOs had a strong negative effect on A. bisporus yield at the first flush when
applied on day 13 after casing, with reductions of 45% and 44% in EO1A and EO3A, respectively,
compared with the control©. These reductions were even greater compared with the yield obtained
with MTF, the differences with EO1A and EO3A being statistically significant. However, in treatments
applied 10 days after casing (EO1B and EO3B) the reduction in yield was less pronounced, 15% and
3%, respectively, compared with the control (C). Nevertheless, the yield obtained at the second flush
compensated for the drop in production at the first flush, and all EO treatments provided higher
yields than the control and MTF treatment (14% increase in EO1B and 95% in EO3A, compared with
the control). At the end of crop cycle, neither the total production nor biological efficiency showed
significant differences among the different treatments applied. As regards earliness, there was a slight
delay (0.6–1.4 days) in the harvest of the first flush in all treatments involving EOs, with significant
differences between the control C and MTF and EO1B, EO3B, and EO3A. In other words, the EO
treatments had a strong fungitoxic effect during the first flush.
4. Discussion
The fungicidal effect of five EOs from Mediterranean aromatic plants on the mycopathogenic
fungus C. mycophilum was assessed in this study. In vitro bioassays showed that S. montana and
T. vulgaris EOs had the greatest inhibitory effect against C. mycophilum, while S. lavandulifolia, L. ×
intermedia and T. mastichina EOs were the least effective. The essential oils of S. montana and T. vulgaris
were characterized by the phenolic compounds, carvacrol and thymol, which are consistent with the
results of other studies [36,37]. Satureja montana contained a higher concentration of carvacrol (17.22%)
than the other essential oils. Thymol was the main component of T. vulgaris oil (25.78%). These two EOs
contained a significant proportion of biological precursors of the phenolic components, γ-terpinene
and p-cymene. Carvacrol and thymol have been shown to have an important antifungal effect, causing
damage in the cell membrane by interacting with sterols, particularly ergosterol [38,39]. However, the
antifungal activity cannot be attributed to a single component, because there are many compounds
acting synergistically [37,40,41]. For example, γ-terpinene and p-cymene, biological precursors of
carvacrol, are not effective antibacterial agents when used alone, but, when combined with carvacrol,
there is a synergism to facilitate the transport of carvacrol across the cytoplasmic membrane of
fungi [41,42]. The essential oils of C. zeylanicum (cinnamon), O. vulgare (oregano), S. aromaticum (clove),
Pogostemon cablin Benth. (patchouli), T. vulgaris (thyme), M. alternifolia (tea tree), Mentha piperita L.
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(peppermint), and Pelargonium graveolens L’Hér. (geranium) also showed antifungal activity against
Cladobotryum sp. [22,43,44].
On the other hand, in vitro bioassays showed that S. lavandulifolia, S. montana, and T. vulgaris
EOs were the least effective in inhibiting the mycelial growth of A. bisporus, while L. × intermedia
and T. mastichina EOs were the most effective. In this case, the results were in contrast to those
obtained in the bioassays with C. mycophilum. That is, the EOs of S. montana and T. vulgaris had
greater antifungal activities against C. mycophilum than A. bisporus. These EOs, the only ones that
contained thymol or carvacrol in their composition, showed no antifungal activity against A. bisporus.
The reason for this low antifungal activity against A. bisporus may reflect the physiological trait of the
mushroom to produce lignolytic enzymes, especially laccase and manganese peroxidase, which are able
to decompose the phenolic compounds, while the materials produced by degradation are consumed
by the mushroom [18,45,46].
The antifungal activity of L. × intermedia (ED50 = 146.6 mg L−1) and T. mastichina EOs (ED50 =
175.7 mg L-1) against A. bisporus could be attributed to the content of alcoholic monoterpenoids, which
include linalool and linalyl acetate [15,42]. Other essential oils, like M. alternifolia and P. graveolens EOs,
also showed in vitro toxicity against A. bisporus (ED50 = 98.0 and 128.36 mg L−1, respectively) [18,22].
The fungitoxic selectivity between the pathogen (C. mycophilum) and the host (A. bisporus) expressed
by the selectivity indexes of the tested EOs indicated that S. montana and T. vulgaris EOs were the most
selective essential oils (SI = 0.08 and 0.09, respectively). These values (lower than 0.1) are better than
those obtained in previous studies with the fungicides chlorothalonil and thiophanate-methyl (SI =
0.38 and 0.21, respectively). However, the fungicides metrafenone, prochloraz-Mn, and thiabendazole
showed better selectivity than the EOs tested (SI = 0.00001, 0.0031, and 0.01, respectively) [13]. On the
other hand, L. x intermedia and T. mastichina EOs had the greatest inhibitory effect against the A. bisporus
mycelium, and their selectivity indexes were the highest (Table 3).
The results obtained using the two most selective essential oils, S. montana and T. vulgaris,
in the cropping trials with inoculated treatments of C. mycophilum indicated that both EOs were
effective when used at the higher doses (1% concentration) (Figure 2). The T. vulgaris (IEO3B, IEO3A)
and S. montana (IEO1A) EOs treatments, at 1% concentration, were as effective as those involving
metrafenone. Until now, the most effective treatment for controlling cobweb disease has been with
metrafenone [13]. These results agree with those of previous studies carried out in mushroom growing
rooms, which showed that the preventative use of T. vulgaris oil was able to control the development
of wet bubble disease caused by Mycogone perniciosa in mushrooms with no detrimental effect on
the growth of A. bisporus, and provided an overall yield similar to that following the application of
a commercial fungicide [20]. On the other hand, there no were significant differences between EO
treatments applied before and after inoculation with conidia of C. mycophilum.
5. Conclusions
According to the obtained results, S. montana and T. vulgaris EOs showed potent in vitro antifungal
activity against C. mycophilum compared with other EOs tested. These EOs were characterized by
the presence of phenolic compounds such as carvacrol and thymol which were absent in the other
EOs tested. In addition, the fungitoxic selectivity between C. mycophilum and A. bisporus indicated
that S. montana and T. vulgaris EOs were the most selective of the essential oils tested. When used in
mushroom growing trials and applied at a later time compared with standard fungicide products,
the two EOs tested showed some efficacy at controlling cobweb disease when used at the 1% rate,
especially T. vulgaris, but additional trials are needed to confirm this observation. However, there was
a strong fungitoxic effect at the first flush, which increased with the time of application nearing the
harvest period, although at the end of the crop cycle there were no differences between treatments
in terms of biological efficiency. These results suggest that T. vulgaris and S. montana essential oils
may be efficacious in managing cobweb disease if used as part of an integrated pest management
(IPM) program.
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